Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations

Natalia Timofeeva, Breana Herrera, Hitomi Fujiwara, Tokiko Asami, Hiroko Endo, Mariko Hatakeyama, Fumio Nakajima, Hiroshi Ohmoto, Yu Nishioka, Kyoko Miyamoto, Akinori Arimura, Shady I Tantawy, Javier Pinilla-Ibarz, Catherine C Coombs, Nitin Jain, Masaaki Sawa, Varsha Gandhi · 2026

Read Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations by Natalia Timofeeva, Breana Herrera, Hitomi Fujiwara, Tokiko Asami, Hiroko Endo, Mariko Hatakeyama, Fumio Nakajima, Hiroshi Ohmoto, Yu Nishioka, Kyoko Miyamoto, Akinori Arimura, Shady I Tantawy, Javier Pinilla-Ibarz, Catherine C Coombs, Nitin Jain, Masaaki Sawa, Varsha Gandhi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13319122.txt.

Description

Natalia Timofeeva and co-authors test a new drug against resistant leukemia in this 2026 paper. Drugs that block the BTK enzyme are standard care for chronic lymphocytic leukemia, but cancers mutate the enzyme and escape. Later drugs cover some mutants, yet new ones, sometimes two at once, defeat those too.

The new drug, docirbrutinib, was tested against 14 mutant forms of the enzyme in lab assays, cell lines, and patient cells. It blocked the enzyme and slowed mutant cell growth, beating two older drugs on some mutants. In patient samples it cut receptor signaling and made cells more sensitive to two other drugs. Early results from a dose-rising trial in patients are also reported.

Catalog record

CREATORNatalia Timofeeva, Breana Herrera, Hitomi Fujiwara, Tokiko Asami, Hiroko Endo, Mariko Hatakeyama, Fumio Nakajima, Hiroshi Ohmoto, Yu Nishioka, Kyoko Miyamoto, Akinori Arimura, Shady I Tantawy, Javier Pinilla-Ibarz, Catherine C Coombs, Nitin Jain, Masaaki Sawa, Varsha Gandhi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13319122

Browse the full library · About the Tower of Babel